1. Management of breast cancer: from standardization to personalization

   • Hideo Inaji

   Conference Paper 04 September 2009 Pages: 239 - 240

2. From standardization to personalization in breast cancer treatment

   • Shinzaburo Noguchi
   • Masakazu Toi

   Conference Paper 07 April 2009 Pages: 241 - 242

3. Breast cancer risk assessment for possible tailored screening for Japanese women

   • Yasuhiro Tamaki
   • Yasuyuki Kotsuma
   • Shinzaburo Noguchi

   Conference Paper 23 May 2009 Pages: 243 - 247

   

4. Algorithm for in vitro diagnostic multivariate index assay

   • Kikuya Kato

   Conference Paper 08 July 2009 Pages: 248 - 251

   

5. Triple negative breast cancer: clinicopathological characteristics and treatment strategies

   • Futoshi Akiyama
   • Hirotaka Iwase

   Conference Paper 09 June 2009 Pages: 252 - 253

   

6. Clinicopathological characteristics of triple-negative breast cancers

   • Yuka Sasaki
   • Hitoshi Tsuda

   Conference Paper 06 August 2009 Pages: 254 - 259

   

7. Clinical significance of basal-like subtype in triple-negative breast cancer

   • Yutaka Yamamoto
   • Mutsuko Ibusuki
   • Hirotaka Iwase

   Conference Paper 22 August 2009 Pages: 260 - 267

   

8. Contemplating chemosensitivity of basal-like breast cancer based on BRCA1 dysfunction

   • Tomohiko Ohta
   • Wenwen Wu
   • Mamoru Fukuda

   Conference Paper 21 May 2009 Pages: 268 - 274

   

9. Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics

   • Junichi Kurebayashi

   Conference Paper 01 May 2009 Pages: 275 - 280

   

10. Estrogen receptor-β status influences clinical outcome of triple-negative breast cancer

    • Goi Sakamoto
    • Naoko Honma

    Conference Paper 22 April 2009 Pages: 281 - 282

11. Recent trends of HER-2 examination and a new strategy of trastuzumab therapy for primary and metastatic breast cancer

    • Masafumi Kurosumi

    Special Feature 10 September 2009 Pages: 283 - 283

12. Recent trends of HER-2 testing and trastuzumab therapy for breast cancer

    • Masafumi Kurosumi

    Special Feature 06 August 2009 Pages: 284 - 287

    

13. Neo(adjuvant) trastuzumab treatment: current perspectives

    • Hiroji Iwata

    Special Feature 17 July 2009 Pages: 288 - 294

    

14. The role of trastuzumab in the management of HER2-positive metastatic breast cancer: an updated review

    • Yutaka Tokuda
    • Yasuhiro Suzuki
    • Shinobu Umemura

    Special Feature 17 July 2009 Pages: 295 - 300

    

15. Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes

    • Masahiko Tanabe
    • Yoshinori Ito
    • Kiyohiko Hatake

    Original Article 10 February 2009 Pages: 301 - 306

    

16. A cluster of microcalcifications: women with high risk for breast cancer versus other women

    • Takayoshi Uematsu
    • Masako Kasami
    • Sachiko Yuen

    Original Article 07 April 2009 Pages: 307 - 314

    

17. Acknowledgment to reviewers 2009

    Acknowledgment 03 October 2009 Pages: 315 - 315